| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/19/2011 | US20110117170 Controlled Release of Growth Factors and Signaling Molecules for Promoting Angiogenesis |
| 05/19/2011 | US20110117168 Methods and compositions for soft tissue repair |
| 05/19/2011 | US20110117167 Methods and compositions for soft tissue repair |
| 05/19/2011 | US20110117164 Use of Additive Sites to Control Nitric Oxide Release from Nitric Oxide Donors Contained within Polymers |
| 05/19/2011 | US20110117136 Dehydroepiandrosterone production promoter and use thereof |
| 05/19/2011 | US20110117112 Sodium channel protein type iii alpha-subunit splice variant |
| 05/19/2011 | US20110117084 Vandetanib derivatives |
| 05/19/2011 | US20110117079 Therapeutic dll4 binding proteins |
| 05/19/2011 | US20110117073 Protein Kinase Conjugates and Inhibitors |
| 05/19/2011 | US20110117069 Method for activating regulatory t-cells |
| 05/19/2011 | US20110117064 Assay for the prediction of therapeutic effectiveness of mesenchymal stromal cells, and methods of using same |
| 05/19/2011 | US20110117053 Method of modulating fibroblast accumulation or collagen deposition |
| 05/19/2011 | US20110117021 Fully human anti-vap-1 monoclonal antibodies |
| 05/19/2011 | US20110117017 Peptides with properties of an allosteric antagonist selective for the alpha 1a adrenergic receptor and uses thereof |
| 05/19/2011 | US20110117015 Diagnostic Agents Selective Against Metalloproteases |
| 05/19/2011 | US20110117008 Use of avicins to deliver therapeutic and diagnostic agents |
| 05/19/2011 | DE102009053089A1 Stoffgemisch auf Basis einer Misching von ätherischen Ölen und Verwendung Mixture based on a Misching of essential oils and use |
| 05/19/2011 | CA2780382A1 Pemirolast for the treatment of systemic low grade inflammation |
| 05/19/2011 | CA2779508A1 Method and compositions for treating disease or condition related to orexin receptor 1, orexin receptor 2, somatostatin receptor 2 or dopamine d2l receptor |
| 05/19/2011 | CA2778175A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 05/18/2011 | EP2322601A1 Method of collecting placental stem cells |
| 05/18/2011 | EP2322551A2 Compositions comprising Anti-IGF-1R Antibodies and Methods for their Production |
| 05/18/2011 | EP2322550A1 Compositions comprising anti-IGF-1R Antibodies and Methods for obtaining said Antibodies |
| 05/18/2011 | EP2322545A1 Analogues of GLP-1 |
| 05/18/2011 | EP2322541A1 Gq protein competitive inhibitory polypeptides, preparation methods and uses thereof |
| 05/18/2011 | EP2322521A1 Heteroaryl compounds useful as inhibitors of GSK-3 |
| 05/18/2011 | EP2322513A2 Intermediates |
| 05/18/2011 | EP2322505A1 1-adamantylazetidin-2-one derivative and pharmaceutical preparation comprising same |
| 05/18/2011 | EP2322501A1 4-dedimethylamino tetracycline compounds |
| 05/18/2011 | EP2322218A1 Methods of modulating CD200 receptors |
| 05/18/2011 | EP2322210A1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 05/18/2011 | EP2322193A1 Xanthine oxidase inhibitor and uric acid production inhibitor |
| 05/18/2011 | EP2322187A2 Use of uridine in combination with choline for the treatment of memory disorders |
| 05/18/2011 | EP2322179A1 Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders |
| 05/18/2011 | EP2322178A2 Use of toll-like receptor ligands in treating excitotoxic injury, ischemia and/or hypoxia |
| 05/18/2011 | EP2322175A1 Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof |
| 05/18/2011 | EP2322174A2 Combined use of valsartan and calcium channel blockers for therapeutic purposes |
| 05/18/2011 | EP2322172A1 Use of celivarone for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level due to celivarone administration |
| 05/18/2011 | EP2322154A2 Methods for detecting and clearing cross beta structure comprising proteins with crossbeta structure binding compounds. |
| 05/18/2011 | EP2321296A1 Substituted 5-aminopyrazoles and use thereof |
| 05/18/2011 | EP2321285A1 Diazepan and piperazine derivatives modulators of chemokine receptors |
| 05/18/2011 | EP2321283A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors |
| 05/18/2011 | EP2320948A1 Methods for treating reperfusion injuries |
| 05/18/2011 | EP2320937A2 Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa |
| 05/18/2011 | EP2320933A1 Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure |
| 05/18/2011 | EP2320887A1 Pharmaceutical compositions comprising lignans and their derivatives for treating hyperplastic diseases |
| 05/18/2011 | EP2320877A1 Treatment of acute myocardial infarction (ami) using encapsulated cells encoding and secreting glp-1 peptides or analogs thereof |
| 05/18/2011 | EP2320740A1 Pharmaceutical compositions and methods for producing low impurity concentrations of the same |
| 05/18/2011 | EP2079709B1 Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticals |
| 05/18/2011 | EP1753418B1 Compositions comprising nebivolol |
| 05/18/2011 | EP1478764B1 Humanized collagen antibodies and related methods |
| 05/18/2011 | EP1268096B9 Extrusion die |
| 05/18/2011 | CN1989986B Chuanxiong rhizome effective ingredient, preparing, preparation method and use thereof |
| 05/18/2011 | CN1989984B Chuanxiong rhizome effective ingredient, preparing method, preparation and use thereof |
| 05/18/2011 | CN1872080B Drop pills of thevetoside and preparation method |
| 05/18/2011 | CN1798831B Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains |
| 05/18/2011 | CN1527704B Compositions and method of administering tubulin binding agents for the treatment of ocular diseases |
| 05/18/2011 | CN102066421A Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-MSK) and atrial natriuretic protein (ANP) and uses in hypertension and acute kidney injury |
| 05/18/2011 | CN102066412A Treatment of diseases and conditions mediated by eicosanoids |
| 05/18/2011 | CN102066397A Compounds including an anti-inflammatory pharmacore and methods of use |
| 05/18/2011 | CN102066385A New peptidomimetic compounds |
| 05/18/2011 | CN102066366A Novel substituted pyridin-2-ones and pyridazin-3-ones |
| 05/18/2011 | CN102066365A Thiophene or thiazole derivatives and their use as PI3K inhibitors |
| 05/18/2011 | CN102066359A Novel heteroaryl carboxamide derivatives |
| 05/18/2011 | CN102066340A 2, 6-diamino-pyrimidin- 5-yl-carboxamides as SRK or JAK kinases inhibitors |
| 05/18/2011 | CN102066339A 2, 6-diamino- pyrimidin- 5-yl-carboxamides as SYK or JAK kinases inhibitors |
| 05/18/2011 | CN102066338A Inhibitors of protein kinases |
| 05/18/2011 | CN102066326A Pyridone compound |
| 05/18/2011 | CN102066322A Compound having NPY Y5 receptor antagonist activity |
| 05/18/2011 | CN102065883A Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease |
| 05/18/2011 | CN102065857A Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in regulating the potassium level in the blood |
| 05/18/2011 | CN102065856A Combination of dronedarone with at least one diuretic, and therapeutic use thereof |
| 05/18/2011 | CN102065855A Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality |
| 05/18/2011 | CN102061322A Method for preparing polysaccharide, flavone and dietary fiber of peanut hulls in united manner |
| 05/18/2011 | CN102060932A Process method for synchronously producing pueraria starch and pueraria flavonoid |
| 05/18/2011 | CN102060921A High-stability VPAC2 type receptor specific activator MHDBAY, preparation method and application thereof |
| 05/18/2011 | CN102060904A Celosia argentea L. saponin compounds and application thereof |
| 05/18/2011 | CN102060889A Stilbene glycoside derivative |
| 05/18/2011 | CN102060888A Novel compounds |
| 05/18/2011 | CN102060857A Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/18/2011 | CN102060845A Fasudil crystal formation III as well as preparation method and application thereof |
| 05/18/2011 | CN102060844A Fasudil crystal formation IV as well as preparation method and application thereof |
| 05/18/2011 | CN102060842A 3-(substituted xylylenimine-2-yl)-2,6-piperidine diketone polymorph and medical composition |
| 05/18/2011 | CN102060809A Rhein derivatives and preparation and application thereof |
| 05/18/2011 | CN102060808A Cinepazide acid addition salt and preparation method thereof |
| 05/18/2011 | CN102060806A Cytokine inhibitors |
| 05/18/2011 | CN102060732A 5-amino-4-hydroxy-N-aryl azelamide derivatives as well as preparation methods and medical applications thereof |
| 05/18/2011 | CN102058889A Dispersible tablet containing anticoagulants and application thereof |
| 05/18/2011 | CN102058888A Pharmaceutical composition for treatment of abnormal energy metabolism and application thereof |
| 05/18/2011 | CN102058872A Medicinal composition containing Lysinopril and amlodipine besilate and preparation method thereof |
| 05/18/2011 | CN102058870A Medicine for treating rheumatism, rheumatoid arthritis and stroke hemiplegia and preparation method thereof |
| 05/18/2011 | CN102058864A Prescription for treating heart diseases and complications thereof |
| 05/18/2011 | CN102058859A Oral medicine formula for traditional Chinese treatment of viral myocarditis |
| 05/18/2011 | CN102058853A Traditional Chinese medicine for reducing blood pressure and preparation method thereof |
| 05/18/2011 | CN102058845A Medicinal composition for treating macular degeneration |
| 05/18/2011 | CN102058842A Traditional Chinese medicine composition for treating hemiplegic stroke or premonitory apoplexy |
| 05/18/2011 | CN102058841A Medicine for umbilicus external use for treating hypertension and preparation method thereof |
| 05/18/2011 | CN102058836A Medicament composition with effects of resisting thrombus, reducing blood pressure and treating leukemia |
| 05/18/2011 | CN102058835A Chinese medicine composition drop for reducing blood pressure and clearing heat and resisting inflammation and preparation method thereof |
| 05/18/2011 | CN102058834A Traditional Chinese medicine composition dispersible tablet capable of lowering blood pressure, reducing heat and resisting inflammation and preparation method thereof |